Immediate Impact

2 by Nobel laureates 5 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
2024 Standout
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
2023 Standout
2 intermediate papers

Works of William Meekison being referenced

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age
2009
Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
William Meekison 575 727 228 29 914
Nicoline van der Maas 454 696 242 62 1.0k
Susan Partridge 493 671 177 33 884
Roland Guasparini 465 530 167 28 767
Jeanne‐Marie Jacquet 540 834 223 39 1.1k
Luc Hessel 333 638 324 34 1.2k
Swei‐Ju Chang 639 750 164 17 870
Harald Heijbel 337 543 314 22 942
Karen Lewis 535 519 123 17 1.0k
ChrisAnna M. Mink 789 845 174 26 1.0k
Kristen Ehresmann 431 660 190 22 860

All Works

Loading papers...

Rankless by CCL
2026